NEW YORK (GenomeWeb) – Gene-editing technology company Inscripta announced today that its has closed a $55.5 million Series C funding round.

The round was led by Mérieux Développement and Paladin Capital Group, and included existing Inscripta investors Venrock, Foresite, MLS Capital, and NanoDimension.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.